BioSpace News Archive

Seegene Inc. (KQ096530), South Korea’s leading molecular diagnostics company, today reported first-half (H1) revenue in 2022 of KRW 579.9 billion (USD 445.8 million), down 11 percent year-over-year. Operating profit fell 37 percent to KRW 212.7 billion.

A greater focus on preventive healthcare, the need to reduce healthcare costs, more expenditure in digital therapies and increasing prevalence of avoidable chronic illnesses are all likely to drive the growth of the global digital therapeutics market in the near future.

Wilmington, Delaware, United States, Transparency Market Research Inc. – The global antiseptic and disinfectant market was valued at US$ 6.3 Bn in 2017.

Wilmington, Delaware, United States, Transparency Market Research Inc. – The global spine surgery products market is all set to gather noteworthy amounts in revenues in the forecast period of 2017 to 2025, states the recently published report by Transparency Market Research.

Emerging technologies such as biomarker analysis, digital PCR, NGS, pyrosequencing, or Sanger sequencing, digital microfluidic platforms and advanced molecular phenotyping technologies are expected to thrust the growth of the market.

Wilmington, Delaware, United States, Transparency Market Research Inc. – From 2018 to 2026, the market for global liquid biopsy will grow by a substantial value.

In January 2022, Bioretec entered into a supply agreement with Meotec GmbH in Germany for magnesium alloy raw materials for bioresorbable RemeOsTM products.

Chemomab Therapeutics, Ltd., a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, announced financial and operating results for the second quarter ended June 30, 2022 and provided a corporate update.

PLx Pharma Inc. Reports Second Quarter 2022 Results and Provides Business Update.

Leap Therapeutics, Inc. today announced that its Board member, Monica Bertagnolli , MD, has been appointed as the 16th Director of the National Cancer Institute.